trending Market Intelligence /marketintelligence/en/news-insights/trending/fxzfikoklmkhmgfm_aw1mq2 content esgSubNav
In This List

Guggenheim Securities names senior biotech analyst

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Podcast

Street Talk | Episode 99 - Higher rates punish bond portfolios, weigh on bank M&A

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Guggenheim Securities names senior biotech analyst

Michael Schmidt will join Guggenheim Securities in June as a senior analyst and senior managing director as part of the company's expansion of its healthcare research team.

Schmidt will focus on the coverage of biotech companies and will work closely with its therapeutics team.

He has served as an equity research analyst at LEERINK Partners since 2009.

Guggenheim Securities is the investment banking and capital markets division of Guggenheim Partners.